192 related articles for article (PubMed ID: 1714057)
1. Prognosis in AZT myopathy.
Chalmers AC; Greco CM; Miller RG
Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
[TBL] [Abstract][Full Text] [Related]
2. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
Lane RJ; McLean KA; Moss J; Woodrow DF
Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
[TBL] [Abstract][Full Text] [Related]
3. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC
Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
Pezeshkpour G; Illa I; Dalakas MC
Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial myopathy caused by long-term zidovudine therapy.
Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
[TBL] [Abstract][Full Text] [Related]
6. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
[TBL] [Abstract][Full Text] [Related]
8. Myopathy in long-term AZT therapy: clinical, electrophysiological and biopsy study in 67 HIV+ subjects.
Spadaro M; Tilia G; Massara MC; Damiani A; Parisi L; Tomelleri G; D'Offizi G; Morocutti C
Ital J Neurol Sci; 1993 Jun; 14(5):369-74. PubMed ID: 8354633
[TBL] [Abstract][Full Text] [Related]
9. HIV or zidovudine myopathy?
Gherardi R; Chariot P
Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
[No Abstract] [Full Text] [Related]
10. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
[TBL] [Abstract][Full Text] [Related]
11. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
Weissman JD; Constantinitis I; Hudgins P; Wallace DC
Neurology; 1992 Mar; 42(3 Pt 1):619-23. PubMed ID: 1549225
[TBL] [Abstract][Full Text] [Related]
12. HIV or zidovudine myopathy?
Kieburtz K
Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
[No Abstract] [Full Text] [Related]
13. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
[TBL] [Abstract][Full Text] [Related]
15. HIV or zidovudine myopathy?
Dalakas M
Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
[No Abstract] [Full Text] [Related]
16. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
Schröder JM; Bertram M; Schnabel R; Pfaff U
Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
[TBL] [Abstract][Full Text] [Related]
17. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
Till M; MacDonell KB
Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
[No Abstract] [Full Text] [Related]
18. Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study.
Joy JL; Oh SJ
Muscle Nerve; 1989 Mar; 12(3):206-9. PubMed ID: 2725551
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
[TBL] [Abstract][Full Text] [Related]
20. AZT myopathy and HIV-1 polymyositis: one disease or two?
Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
